Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis. - Paller AS; Simpson EL; Siegfried EC; Cork MJ; Arkwright PD; Pinter A; Deleuran M; Hong HC; Ma Y; Bansal A; Dubost-Brama A; Nguyen TV (American journal of clinical dermatology, 2026)